Vertex Pharmaceuticals (VRTX) Cash from Investing Activities (QoQ) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 30.42 Bn | 30.42 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -49.91% |
| Dec 31, 2025 | -146.24% |
| Sep 30, 2025 | 75.85% |
| Jun 30, 2025 | -768.28% |
| Mar 31, 2025 | 93.21% |
| Dec 31, 2024 | -136.18% |
| Sep 30, 2024 | 24.95% |
| Jun 30, 2024 | 78.30% |
| Mar 31, 2024 | -140.99% |
| Dec 31, 2023 | -653.19% |
| Sep 30, 2023 | 61.27% |
| Jun 30, 2023 | 83.43% |
| Mar 31, 2023 | -1,144.19% |
| Dec 31, 2022 | 145.71% |
| Sep 30, 2022 | -524.72% |
| Jun 30, 2022 | -20.59% |
| Mar 31, 2022 | 61.94% |
| Dec 31, 2021 | -153.31% |
| Sep 30, 2021 | 33.63% |
| Jun 30, 2021 | -7.27% |
| Mar 31, 2021 | -130.48% |
| Dec 31, 2020 | 198.31% |
| Sep 30, 2020 | -444.78% |
| Jun 30, 2020 | 127.10% |
| Mar 31, 2020 | 103.53% |
| Dec 31, 2019 | -260.23% |
| Sep 30, 2019 | -396.11% |
| Jun 30, 2019 | -28.24% |
| Mar 31, 2019 | 4.32% |
| Dec 31, 2018 | 18.01% |
| Sep 30, 2018 | 57.10% |
| Jun 30, 2018 | -2,457.55% |
| Mar 31, 2018 | 123.73% |
| Dec 31, 2017 | 90.77% |
| Sep 30, 2017 | -195.32% |
| Jun 30, 2017 | 52.61% |
| Mar 31, 2017 | -190.98% |
| Dec 31, 2016 | 408.57% |
| Sep 30, 2016 | 160.21% |
| Jun 30, 2016 | 43.74% |